Neurovascular Devices Market is expected to Grow at a CAGR of 8.12% by 2030, estimates DelveInsight

Neurovascular Devices companies are Johnson & Johnson, Medtronic, Stryker, Terumo Corporation, Penumbra, Microport Scientific Corporation, Kaneka Corp., more.

ALBANY, NY, UNITED STATES, January 20, 2025 /EINPresswire.com/ -- DelveInsight's Neurovascular Devices Market Insights and Forecast report provides the current and forecast Neurovascular Devices Market, upcoming innovation in the devices, individual market shares, challenges, drivers and barriers, market trends, and key competitors in the Neurovascular Devices Market.
As per DelveInsight Analysis for Neurovascular Devices market, the increasing prevalence of neurological conditions, rising demands for minimally-invasive procedures are some of the key factors, which are expected to increase the overall demand for Neurovascular Devices, thus driving the growth of the Neurovascular Devices market.

Some of the salient features from the Neurovascular Devices Market report:
• As per an analysis by DelveInsight, North America is expected to dominate the overall Neurovascular Devices Market during the forecast period.
• Major pharma players working proactively in the Neurovascular Devices Market include Johnson & Johnson, Medtronic, Stryker, Terumo Corporation, Penumbra, Inc., Microport Scientific Corporation, Kaneka Corp., and others.
• The global Neurovascular Devices market was valued at USD 2.84 billion in 2023, growing at a CAGR of 8.12% during the forecast period from 2024 to 2030, to reach USD 4.53 billion.
• in 2023, Kaneka and Asahi Intecc announced a marketing collaboration for i-ED Coil distribution in the US including marketing material preparation, clinical support, and administration for consignment stock in hospitals. This agreement may also expand to include other product offerings in the future.
• On April 21, 2021, Medtronic had received the FDA approval for Pipeline Flex Embolization Device with Shield Technology.
• On January 07, 2019, Terumo Corporation had announced that FDA had granted the Premarket Approval for the novel Intrasaccular Aneurysm Treatment Device for the treatment of intracranial wide-neck bifurcation aneurysms.

To pick on the latest highlights related to Neurovascular Devices Market, get the snapshot of the key highlights entailed in the report @ Neurovascular Devices Market Forecast

Neurovascular Devices Overview
Neurovascular Devices/Interventional Neurology devices are devices that comprise coils, stents, clot-retrieving devices and other devices for the treatment of neurovascular disorders such as brain aneurysms and neurovascular thrombectomy. Clot retrieval devices, suction and aspiration devices are used in the removal of blood clots from the arteries and veins of the brain that can also lead to stroke. Neurovascular devices are used for the treatment of disorders that are associated with the blood vessels that carry oxygen-rich blood to the brain region.

Interested in knowing how the Neurovascular Devices Market will be growing by 2030? Click to get a snapshot of Neurovascular Devices Market Analysis

Neurovascular Devices Market Insight
Geographically, the global Neurovascular Devices market is studied for North America, Europe, Asia-Pacific, and the Rest of the World. In terms of revenue share North America currently leads the global market and is expected that it will remain constant during the forecast period. This domination in North America is observed majorly due to the growing cases of neurological disorders in the United States that require treatment through Neurovascular Devices.
Owing to the growing patient population suffering from chronic neurological disorders and the launch and approval of embolization devices in various countries, there is an anticipated growth boost for the Neurovascular Devices market. For instance, on April 14, 2020, Keystone Heart Ltd. had announced that their cerebral embolic protection device, named TRIGUARD 3 had been granted the CE Mark approval. Also, on October 21, 2019, Shape Memory Medical had announced that they had received CE Mark approval for the Trellix embolic coil system.
On May 07, 2019, Rapid Medical had announced the Food and Drug Administration approval of the novel Temporary Aneurysm Embolization Assist Device, Comaneci, a new category of temporary coil embolization assists devices.

Learn more about the Neurovascular Devices Market Landscape @ Neurovascular Devices Market Landscape: https://www.delveinsight.com/report-store/neurovascular-devices-interventional-neurology-market?utm_source=einpresswire&utm_medium=pressrelease&utm_campaign=apr

Neurovascular Devices Market Drivers and Barriers
An increase in the prevalence rate of brain aneurysms suffering population, market development related to products and expansions, and the launch as well as approval of new innovative devices will lead to an increased demand for embolization devices, further leading to an increase in the Neurovascular Devices market growth. Apart from that rising incidence of hypertension across the globe leading to brain aneurysms may also lead to significant growth of the Neurovascular Devices market.
The demand for Neurovascular Devices is primarily affected by the outbreak of the COVID-19 pandemic because of the delay in elective surgeries. Undiagnosed and unreported brain aneurysm cases also act as setbacks for the Neurovascular Devices market.

To get a deeper understanding of the driving factors related to the Neurovascular Devices Market, get a snapshot of the Neurovascular Devices Market Dynamics

Scope of the Neurovascular Devices Market Report
Study Period: 2021-2030
Key Companies: Johnson & Johnson, Medtronic, Stryker, Terumo Corporation, Penumbra, Inc., Microport Scientific Corporation, Kaneka Corp.
Neurovascular Devices Market Segmentation
By Product Type
• Cerebral Embolization and Aneurysm Coiling devices
• Embolic Coils
• Flow Diversion Devices
• Liquid Embolic Agents

• Cerebral Balloon Angioplasty and Stenting System
• Embolic Protection Systems
• Carotid Artery Stents

• Neurothrombectomy Devices
• Clot Retrievers
• Suction devices
• Vascular Snare

• Support Devices
• Micro Catheters
• Micro Guidewires

By Application
• Stroke
• Cerebral Aneurysm
• Carotid artery Stents
• Other Diseases

By End-User
• Hospitals
• Ambulatory Surgical Centers

By Geography
• North America
• Europe
• Asia-Pacific
• Rest of World

Delveinsight Analysis: Global Neurovascular Devices/Interventional Neurology Market was valued at USD 2.84 billion in 2023, growing at a CAGR of 8.12% during the forecast period from 2024 to 2030, to reach USD 4.53 billion.

Table of Contents
1. Neurovascular Devices/Interventional Neurology Market Report Introduction
2. Neurovascular Devices/Interventional Neurology Market Executive summary
3. Regulatory and Patent Analysis
4. Neurovascular Devices/Interventional Neurology Market Key factors analysis
5. Neurovascular Devices Porter's Five Forces Analysis
6. COVID-19 Impact Analysis on Neurovascular Devices Market
7. Neurovascular Devices Market Layout
8. Neurovascular Devices Global Company Share Analysis – Key 3-5 Companies
9. Neurovascular Devices/Interventional Neurology Market Company and Product Profiles
9.1 Johnson & Johnson
9.2 Medtronic
9.3 Stryker
9.4 Terumo Corporation
9.5 Penumbra, Inc.
9.6 Microport Scientific Corporation
9.7 Kaneka Corporation
9.8 Integer Holdings Corporation
9.9 phenox GmbH
9.10 Perflow Medical Ltd.
9.11 Balt
9.12 Rapid Medical
9.13 ASAHI INTECC CO., LTD.
9.14 Acandis GmbH
9.15 Cerus Endovascular Inc.
10. Project Approach
11. KOL Views
12. DelveInsight Capabilities
13. Disclaimer
14. About DelveInsight

Learn more about the report offerings @ Neurovascular Devices Market Outlook: https://www.delveinsight.com/sample-request/neurovascular-devices-interventional-neurology-market?utm_source=einpresswire&utm_medium=pressrelease&utm_campaign=apr

About DelveInsight:
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.

Ankit Nigam
DelveInsight Business Research
+1 469-945-7679
email us here
Visit us on social media:
Facebook
X
LinkedIn
Instagram
YouTube